What Happened?
Boston, Massachusetts-based Albireo Pharma Appointed Tyson Kamikawa as Vice President Information Technology
Date of management change: June 25, 2020
Boston, Massachusetts-based Albireo Pharma Appointed Tyson Kamikawa as Vice President Information Technology
Albireo Pharma is a clinical-stage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases, and other liver and gastrointestinal diseases and disorders. Albireo`s lead product candidate, A4250, is directed to treat rare pediatric cholestatic liver diseases and is in Phase 3 development in its initial target indication, progressive familial intrahepatic cholestasis. Albireo`s clinical pipeline also includes two Phase 2 product candidates. Albireo`s elobixibat, approved in Japan for the treatment of chronic constipation, is the first ileal bile acid transporter (IBAT) inhibitor approved anywhere in the world. Albireo was spun out from AstraZeneca in 2008. Albireo Pharma is located in Boston, Massachusetts, and its key operating subsidiary is located in Gothenburg, Sweden.
Tyson Kamikawa is Vice President Information Technology at Syndax. Previously, Tyson held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Ross Christopher, Visca Salvatore, Richards Karl, Johnson Ralph, Pistone Matt, Conlin Patrick, Webb Matt, Goldsmith Steven, Wang George, Skinner Ross, Karam Sam
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.